Women's Health CRO

Be confident in the successful design and conduct of your upcoming Women’s Health clinical trial with guidance from our team of cross-functional therapeutic experts.

Be confident in the successful design and conduct of your upcoming Women’s Health clinical trial with guidance from our team of cross-functional therapeutic experts.

Women's health CRO doctor and patient

Improving healthcare for women
across the globe

Clinical research for women’s health has garnered attention from the pharmaceutical research and drug development space, but is much more than a buzzword. Despite impacting nearly half of the population, women’s health clinical development has increased in complexity, facing hurdles such as steep competition for site resources, patient recruitment challenges, and insufficient cross-therapeutic expertise.

At Medpace, we have a therapeutically aligned leadership team focused specifically on improving women’s health clinical research. We understand the challenges specific to women’s health clinical trial development, informed by our experience across a broad range of therapeutic areas and indications including oncology, infectious diseases, and metabolic disorders. Ultimately, we at Medpace strive to fill the many unmet needs in women’s health and improve healthcare outcomes and quality of life for women across the globe.

Making the Complex Seamless®
in Global Women’s Health
Clinical Trials

The Medpace women’s health team has a deep understanding of the complexity of managing clinical trials in a broad range of conditions, having contributed to over 60 women’s health clinical studies in recent years. 

For over 30 years, Sponsors across emerging biotechnology and global pharmaceutical companies have trusted Medpace to lead their women’s health clinical development.

Women's health CRO doctor

Abstract Network Background

“At Medpace, we recognize the many unmet needs in women’s healthcare as well as the importance of clinical trials focused on diverse groups of women, be it diversity of race, ethnicity, age, or health status. We understand the unique challenges involved with recruiting women in clinical trials. We at Medpace are excited to partner with our Sponsors, who are at the forefront of cutting-edge therapeutics, to facilitate clinical trials focused on Women’s Health and ultimately transform healthcare for women around the globe.”

Aparna Shah, MD
Medical Director, Medical Department,
Women’s Health

Women’s Health CRO Capabilities

 When you partner with Women’s Health CRO Medpace, medical leadership is fully embedded within the clinical trial process from inception to completion to help accelerate development. Your trial will benefit from our in-depth knowledge of disease processes and pathophysiology unique to women, relevant outcome measures, and standards of care. 

Therapeutically-Aligned Medical Leadership

Medpace medical leadership and expertise in Women’s Health spans multiple therapeutic areas and indications, including Gynecology, Urogynecology, Oncology, Endocrinology and Metabolic Disease, and Infectious Disease and Vaccines (ID&V)

Diverse Therapeutic Expertise

The intersection of Women’s Health and related diverse disciplines is handled through the collaboration of our medical leadership and functional areas. Medpace accelerates Women’s Health development by fully embedding medical leadership and a wide array of relevant therapeutic expertise, integrated across all functional areas, into the clinical trial process. This cross-therapeutic and cross-functional area collaboration allows for optimized trial communication and execution, and ultimately, expedited timelines. 

doctor reviews patient records on desktop PC

Gynecologic Expertise

Motivated by the many gaps in currently available treatment options for a variety of Gynecologic conditions, the Medpace Women’s Health experts apply their expertise in Gynecology throughout the clinical research process. Ensure success by partnering with Medpace to proactively anticipate challenges relevant to Gynecologic clinical trials. Our team will creatively approach study design and patient recruitment to optimize trial execution, with a continual focus on diverse populations of women.   

Key Indications Include:

  • Contraception
  • Sexually Transmitted Infections
    • Genital Herpes Simplex
    • Gonorrhea
    • Chlamydia
    • Syphilis
    • Human Papillomavirus
    • Trichomonas
    • Bacterial Vaginosis
    • Candida
  • Vulvovaginitis
  • Abnormal Uterine Bleeding
  • Uterine Fibroids / Polyps
  • Endometriosis
  • Adenomyosis
  • Infertility
  • Intrauterine Adhesions
  • Polycystic Ovary Syndrome
  • Ovarian Cysts
  • Cervical Dysplasia Prevention
  • Female Sexual Interest / Arousal Disorder
  • Menopause / Perimenopause
  • Osteoporosis / Osteopenia 
group of businesswomen brainstorming ideas

Urogynecologic Expertise

Our Medpace Women’s Health experts hold extensive experience in Urogynecologic conditions. Our medical experts provide leadership in a broad array of Urogynecologic conditions, having clinically managed the full spectrum of pelvic floor disorders. At Medpace, our in-depth clinical experience combined with our comprehensive research experience translates into our ability to successfully design and execute your Urogynecologic clinical trials in the most efficient and effective way possible.

Key Indications Include:

  • Overactive Bladder 
  • Urinary Incontinence  
    • Stress Urinary Incontinence
    • Urge Urinary Incontinence
    • Mixed Urinary Incontinence
  • Voiding Dysfunction / Incomplete Bladder Emptying / Neurogenic Bladder
  • Urinary Tract Infections
    • Uncomplicated Urinary Tract Infections
    • Complicated Urinary Tract Infections
    • Recurrent Urinary Tract Infections
  • Fecal Incontinence
  • Pelvic Organ prolapse
  • Genitourinary Syndrome of Menopause / Vaginal Atrophy 
  • Vulvar Disorders (Lichen Sclerosis, Lichen Planus)
  • Chronic Pelvic Pain / Dyspareunia
  • Interstitial Cystitis / Bladder Pain Syndrome 

Women’s Cancers Expertise

Our Medpace Women’s Cancer experts include board certified oncologists with extensive experience treating women with breast, ovarian, cervical, endometrial, vaginal, and vulvar cancers. From early stage cancers to progressive, metastatic disease, this expertise includes management with various chemotherapeutics, radiation therapies, immuno-oncologic agents, and other novel cancer therapies. At Medpace, our in-depth clinical and research experience translates to our ability to successfully facilitate the design and execution of global oncology clinical trials.

Key Indications Include:

  • Breast Cancer 
  • Cervical Cancer 
  • Endometrial Cancer 
  • Uterine Cancer
  • Ovarian Cancer 
  • Vaginal Cancer 
  • Vulvar Cancer

Endocrine & Metabolic Expertise

Experienced in broad range of endocrine and metabolic conditions in variable populations, our Women’s Health endocrine specialists provide leadership in indications resulting from physiologic as well as non-physiologic hormonal changes. Our highly qualified team will advise optimal study design for your endocrine and metabolic focused clinical trial and provide scientific medical oversight of the clinical program in order to execute your clinical trial in the most seamless way possible.

Key Indications Include:

  • Osteoporosis 
  • Polycystic Ovary Syndrome
  • VMS of Menopausal
  • Obstetrics
    • Gestational Diabetes
    • Hyperemesis Gravidarum
    • Hypothyroxinemia in Pregnancy / Thyroid Disease in Pregnancy
    • Preterm Birth
    • Pre-eclampsia

Vaccine Expertise

Our Medpace ID&V team has extensive experience in designing and conducting infectious disease clinical trials. Our experts have broad clinical experience in managing the full spectrum of infectious diseases which can disproportionately affect women and have additional downstream complications. Our team fully understands the unique challenges to running infectious disease trials in women. Our combined expertise in Women’s Health, Infectious Disease and Vaccines translates into optimal study design and execution with the goal of continued advancement for the prevention and treatment of infectious diseases in women.  

Key Indications Include:

  • Human Papillomavirus